CanSino Biologics

OverviewSuggest Edit

CanSino Biologics is a biotechnology company dedicated to the R&D, manufacturing, and commercialization of vaccine products for human use. CanSino’s mission is to develop high-value and high-quality vaccines for China and other emerging countries at an affordable cost. Equipped with cutting-edge scientific know-how and technology, CanSino’s goal is to lead and foster the Chinese vaccine industry into a major contributor to global public health.

TypePrivate
Founded2009
Websitecansinotech.com

Latest Updates

Employees (est.) (May 2017)166,741

CanSino Biologics Financials and Metrics

Summary Metrics

Founding Date

2009

CanSino Biologics total Funding

$76 m

CanSino Biologics latest funding size

$65 m

Time since last funding

3 years ago

CanSino Biologics investors

CanSino Biologics's latest funding round in April 2017 was reported to be $65 m. In total, CanSino Biologics has raised $76 m
Show all financial metrics

CanSino Biologics Online and Social Media Presence

Embed Graph

CanSino Biologics Frequently Asked Questions

  • When was CanSino Biologics founded?

    CanSino Biologics was founded in 2009.

  • How many employees does CanSino Biologics have?

    CanSino Biologics has 166,741 employees.

  • Who are CanSino Biologics competitors?

    Competitors of CanSino Biologics include AstraZeneca, Molecular Templates and Lineage Cell Therapeutics.